v3.25.4
SEGMENTS AND GEOGRAPHIC REGIONS - Reconciliation of Segment Operating EBITDA to Income from Continuing Operations Before Income Taxes (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2025
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Segment Reporting Information [Line Items]                      
Depreciation and amortization                 $ 647 $ 635 $ 580
Interest income                 72 74 155
Interest expense                 311 365 396
Non-operating pension/OPEB Benefit credits (costs)                 5 9 (13)
Foreign exchange gains (losses), net                 (34) (3) (77)
Future reimbursable indirect costs                 89 100 106
Remediation costs associated with divested businesses                 12 14 22
Significant items charge                 (412) (380) (784)
Income (loss) from continuing operations before income taxes $ (66) $ 91 $ 78 $ 97 $ (199) $ 287 $ 1 $ 28 200 117 (279)
Healthcare & Water Technologies                      
Segment Reporting Information [Line Items]                      
Operating EBITDA                 972 844 866
Diversified Industrials                      
Segment Reporting Information [Line Items]                      
Operating EBITDA                 800 839 792
Operating Segments                      
Segment Reporting Information [Line Items]                      
Operating EBITDA                 1,772 1,683 1,658
Operating Segments | Healthcare & Water Technologies                      
Segment Reporting Information [Line Items]                      
Operating EBITDA                 972 844 866
Significant items charge                 (19) (41) (41)
Operating Segments | Diversified Industrials                      
Segment Reporting Information [Line Items]                      
Operating EBITDA                 800 839 792
Significant items charge                 (22) (55) (687)
Corporate                      
Segment Reporting Information [Line Items]                      
Operating EBITDA                 (144) (152) (114)
Significant items charge                 $ (371) $ (284) $ (56)